- Home
- SGMT vs SCPH Comparison
SGMT vs SCPH Comparison
Compare SGMT & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- SCPH
- Stock Information
- Founded
- SGMT 2006
- SCPH 2013
- Country
- SGMT United States
- SCPH United States
- Employees
- SGMT N/A
- SCPH N/A
- Industry
- SGMT
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- SGMT
- SCPH Health Care
- Exchange
- SGMT Nasdaq
- SCPH Nasdaq
- Market Cap
- SGMT 165.4M
- SCPH 173.6M
- IPO Year
- SGMT 2023
- SCPH 2017
- Fundamental
- Price
- SGMT $4.12
- SCPH $3.25
- Analyst Decision
- SGMT Strong Buy
- SCPH Strong Buy
- Analyst Count
- SGMT 7
- SCPH 2
- Target Price
- SGMT $25.71
- SCPH $15.00
- AVG Volume (30 Days)
- SGMT 864.8K
- SCPH 261.4K
- Earning Date
- SGMT 03-24-2025
- SCPH 03-12-2025
- Dividend Yield
- SGMT N/A
- SCPH N/A
- EPS Growth
- SGMT N/A
- SCPH N/A
- EPS
- SGMT N/A
- SCPH N/A
- Revenue
- SGMT N/A
- SCPH $30,278,000.00
- Revenue This Year
- SGMT N/A
- SCPH $172.27
- Revenue Next Year
- SGMT N/A
- SCPH $131.75
- P/E Ratio
- SGMT N/A
- SCPH N/A
- Revenue Growth
- SGMT N/A
- SCPH 303.87
- 52 Week Low
- SGMT $2.39
- SCPH $3.08
- 52 Week High
- SGMT $7.64
- SCPH $6.54
- Technical
- Relative Strength Index (RSI)
- SGMT 43.11
- SCPH 43.27
- Support Level
- SGMT $3.96
- SCPH $3.09
- Resistance Level
- SGMT $4.83
- SCPH $3.87
- Average True Range (ATR)
- SGMT 0.38
- SCPH 0.20
- MACD
- SGMT -0.04
- SCPH 0.00
- Stochastic Oscillator
- SGMT 13.39
- SCPH 20.65
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.